Insmed, Inc. (INSM): Price and Financial Metrics

Insmed, Inc. (INSM): $27.13

0.19 (-0.70%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add INSM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#149 of 365

in industry

INSM Price/Volume Stats

Current price $27.13 52-week high $32.00
Prev. close $27.32 52-week low $16.25
Day low $27.01 Volume 1,129,600
Day high $27.55 Avg. volume 1,648,874
50-day MA $27.77 Dividend yield N/A
200-day MA $25.22 Market Cap 4.03B

INSM Stock Price Chart Interactive Chart >

INSM POWR Grades

  • INSM scores best on the Value dimension, with a Value rank ahead of 60.33% of US stocks.
  • The strongest trend for INSM is in Growth, which has been heading up over the past 26 weeks.
  • INSM ranks lowest in Momentum; there it ranks in the 10th percentile.

INSM Stock Summary

  • INSMED INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 5.39% of US listed stocks.
  • INSM's price/sales ratio is 14.61; that's higher than the P/S ratio of 92.6% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -14.78 for INSMED INC; that's greater than it is for only 1.74% of US stocks.
  • If you're looking for stocks that are quantitatively similar to INSMED INC, a group of peers worth examining would be APLT, CYTK, FGEN, NVAX, and CPTN.
  • Visit INSM's SEC page to see the company's official filings. To visit the company's web site, go to www.insmed.com.

INSM Valuation Summary

  • INSM's price/earnings ratio is -6.1; this is 120.93% lower than that of the median Healthcare stock.
  • INSM's price/sales ratio has moved down 790.2 over the prior 243 months.

Below are key valuation metrics over time for INSM.

Stock Date P/S P/B P/E EV/EBIT
INSM 2023-12-29 15.8 -15.3 -6.1 -8.2
INSM 2023-12-28 16.2 -15.7 -6.3 -8.4
INSM 2023-12-27 16.1 -15.6 -6.3 -8.4
INSM 2023-12-26 15.8 -15.3 -6.1 -8.2
INSM 2023-12-22 15.3 -14.9 -5.9 -8.0
INSM 2023-12-21 15.0 -14.5 -5.8 -7.9

INSM Growth Metrics

    Its 4 year cash and equivalents growth rate is now at 240.87%.
  • Its 2 year cash and equivalents growth rate is now at 20.23%.
  • Its year over year cash and equivalents growth rate is now at 25.86%.
Over the past 70 months, INSM's revenue has gone up $245,358,000.

The table below shows INSM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 245.358 -400.439 -481.534
2022-09-30 242.182 -381.422 -434.389
2022-06-30 221.209 -367.039 -415.958
2022-03-31 201.354 -340.182 -437.634
2021-12-31 188.461 -363.302 -434.654
2021-09-30 173.752 -345.962 -423.889

INSM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INSM has a Quality Grade of C, ranking ahead of 31.6% of graded US stocks.
  • INSM's asset turnover comes in at 0.172 -- ranking 207th of 682 Pharmaceutical Products stocks.
  • CYRX, CTLT, and ACOR are the stocks whose asset turnover ratios are most correlated with INSM.

The table below shows INSM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.172 0.760 -0.609
2021-06-30 0.192 0.753 -0.585
2021-03-31 0.209 0.754 -0.551
2020-12-31 0.206 0.757 -0.513
2020-09-30 0.215 0.776 -0.415
2020-06-30 0.214 0.795 -0.422

INSM Price Target

For more insight on analysts targets of INSM, see our INSM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $51.78 Average Broker Recommendation 1.4 (Strong Buy)

Insmed, Inc. (INSM) Company Bio


Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.


INSM Latest News Stream


Event/Time News Detail
Loading, please wait...

INSM Latest Social Stream


Loading social stream, please wait...

View Full INSM Social Stream

Latest INSM News From Around the Web

Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.

Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 Shares

On December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing.

Yahoo | December 23, 2023

Investors ignore increasing losses at Insmed (NASDAQ:INSM) as stock jumps 9.0% this past week

If you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience...

Yahoo | December 7, 2023

12 Most Promising Stocks to Buy According to Hedge Funds

In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Hedge Funds. Analysts and financial institutions are starting to release their 2024 market outlook reports and predictions and you […]

Yahoo | December 5, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 14 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

Yahoo | December 5, 2023

Insmed To Present at the Nasdaq 49th Investor Conference

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT.

Yahoo | November 29, 2023

Read More 'INSM' Stories Here

INSM Price Returns

1-mo -3.21%
3-mo -12.46%
6-mo 7.45%
1-year 61.87%
3-year -15.95%
5-year -6.67%
YTD -12.46%
2023 55.11%
2022 -26.65%
2021 -18.17%
2020 39.41%
2019 82.01%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!